Eli Lilly says it will build four manufacturing plants that are expected to start producing medicines within five years.
Mandatory Credit: Mike Segar/Reuters via CNN Newsource
Stories this photo appears in:
Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals.
